Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIK FOR TAND-, MUND- OG KÆBEKIRURGI I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.0% 1.9% 4.8% 5.5% 7.4% 6.4% 14.5% 14.3%   Credit score (0-100)   71 71 45 40 32 36 15 15   Credit rating   A A BBB BBB BB BBB BB BB   Credit limit (kDKK)   2.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   11,562 9,799 16,230 17,038 20,423 19,401 0.0 0.0   EBITDA   7,564 5,894 12,038 12,356 13,993 10,764 0.0 0.0   EBIT   5,979 4,213 10,361 10,765 12,776 9,537 0.0 0.0   Pre-tax profit (PTP)   5,859.3 4,146.1 10,054.0 10,424.9 12,250.3 9,037.6 0.0 0.0   Net earnings   5,859.3 4,146.1 10,054.0 10,424.9 12,250.3 9,037.6 0.0 0.0   Pre-tax profit without non-rec. items   5,859 4,146 10,054 10,425 12,250 9,038 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   7,101 6,275 5,097 4,281 4,081 3,405 0.0 0.0   Shareholders equity total   8,877 5,907 8,243 4,913 4,182 3,008 0.0 0.0   Interest-bearing liabilities   1,128 535 424 224 66.8 419 0.0 0.0   Balance sheet total (assets)   10,919 7,582 9,807 6,266 5,207 4,918 0.0 0.0   Net Debt   -984 418 -3,516 -688 -338 -171 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,562 9,799 16,230 17,038 20,423 19,401 0.0 0.0   Gross profit growth   9.2% -15.2% 65.6% 5.0% 19.9% -5.0% -100.0% 0.0%   Employees   11 10 10 10 12 15 0 0   Employee growth %   0.0% -9.1% 0.0% 0.0% 20.0% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   10,919 7,582 9,807 6,266 5,207 4,918 0 0   Balance sheet change%   2.1% -30.6% 29.3% -36.1% -16.9% -5.5% -100.0% 0.0%   Added value   7,564.1 5,894.3 12,038.2 12,356.3 14,367.5 10,764.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,607 -2,507 -2,855 -2,407 -1,418 -1,903 -3,405 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.7% 43.0% 63.8% 63.2% 62.6% 49.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   55.4% 45.6% 119.2% 134.0% 222.8% 188.5% 0.0% 0.0%   ROI %   61.6% 50.4% 134.6% 156.1% 272.3% 248.6% 0.0% 0.0%   ROE %   72.3% 56.1% 142.1% 158.5% 269.4% 251.4% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   81.3% 77.9% 84.0% 78.4% 80.3% 61.2% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -13.0% 7.1% -29.2% -5.6% -2.4% -1.6% 0.0% 0.0%   Gearing %   12.7% 9.1% 5.1% 4.6% 1.6% 13.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.8% 8.7% 65.1% 107.3% 364.9% 207.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.5 0.5 3.6 1.2 0.8 0.6 0.0 0.0   Current Ratio   2.2 0.8 3.7 1.4 0.9 0.7 0.0 0.0   Cash and cash equivalent   2,111.7 117.3 3,940.4 911.9 405.0 589.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,984.4 -218.4 3,346.2 484.1 -61.9 -560.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   688 589 1,204 1,236 1,197 718 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   688 589 1,204 1,236 1,166 718 0 0   EBIT / employee   544 421 1,036 1,076 1,065 636 0 0   Net earnings / employee   533 415 1,005 1,042 1,021 603 0 0